Newest studies
Every summary in our library, newest first, as a dated timeline.
Showing 15,626–15,650 of 27,380 studies, newest first · page 626 of 1096.
November 2016 25
-
2016-11-17
Patient and Caregiver Interplay in Behavioral and Psychological Symptoms of Dementia: Family Caregiver's Experience
39/100 ✓ Peer-reviewed Caregiving Clinical nursing research
Key finding: The purpose of this study was to identify family caregivers' experiences in managing the behavioral and psychological symptoms of dementia (BPSD) with particular focus on their interpersonal interactions with patient with dementia.
Full summary, score breakdown and related studies → Original source
-
2016-11-17
Personalising exercise recommendations for brain health: considerations and future directions
39/100 ✓ Peer-reviewed Prevention trials British journal of sports medicine
Key finding: Physical activity-unstructured and structured-is a promising, cost-effective strategy for the promotion of brain health. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-17
The Eye As a Biomarker for Alzheimer's Disease
38/100 ✓ Peer-reviewed Brain scans and imaging Frontiers in neuroscience
Key finding: Though effective, these methods are not widely available due to issues such as the difficulty in acquiring samples, lack of infrastructure or high cost. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-17
A comprehensive database of published tDCS clinical trials (2005-2016)
64/100 ✓ Peer-reviewed Clinical safety Neurophysiologie clinique = Clinical neurophysiology
Key finding: Transcranial direct current stimulation (tDCS) is a technique of noninvasive cortical stimulation allowing significant modification of brain functions. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2016-11-16
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
79/100 ✓ Peer-reviewed Drug development Lancet (London, England)
Key finding: The prespecified primary analyses did not show any treatment benefit at either of the doses tested for the coprimary outcomes (change in ADAS-Cog score compared with control [n=354, 6·32, 95% CI 5·31-7·34]: 75 mg LMTM twice a day [n=257] -0·02, -1·60 to 1·56, p=0·9834, 125 mg LMTM twice a day [n=250] -0·43, -2·06 to 1·20, p=0·9323; change in ADCS-ADL score compared with control [-8·22, 95% CI -9·63 to -6·82]: 75 mg LMTM twice a day -0·93, -3·12 to 1·26, p=0·8659; 125 mg LMTM twice a day -0·34, -2·61 to 1·93, p=0·9479). +2 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-16
MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease
58/100 ✓ Peer-reviewed Treatments The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
Key finding: The MAXCOG intervention is effective in improving goal performance and satisfaction in clients with MCI and early dementia. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2016-11-16
Genetically decreased vitamin D and risk of Alzheimer disease
62/100 ✓ Peer-reviewed Genetics Neurology
Key finding: Our results provide evidence supporting 25OHD as a causal risk factor for AD. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-14
Computerized Cognitive Training in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis
66/100 ✓ Peer-reviewed Prevention trials The American journal of psychiatry
Key finding: CCT is efficacious on global cognition, select cognitive domains, and psychosocial functioning in people with mild cognitive impairment. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-14
Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension
51/100 ✓ Peer-reviewed Risk factors The Journal of clinical investigation
Key finding: These findings unveil a pathogenic role of PVMs in the neurovascular and cognitive dysfunction associated with hypertension and identify these cells as a putative therapeutic target for diseases associated with cerebrovascular oxidative stress.
Full summary, score breakdown and related studies → Original source
-
2016-11-12
Antipsychotic prescribing patterns in a Medicare Advantage population of older individuals with dementia
40/100 ✓ Peer-reviewed Health systems and care delivery Journal of Mental Health
Key finding: Of the 8688 individuals in the Medicare Advantage population with a dementia diagnosis, 1061 (12.2%) received an antipsychotic medication. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-12
Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline
48/100 ✓ Peer-reviewed Inflammation and the immune system Experimental gerontology
Key finding: In particular, aging impairs the increase in cerebral blood flow triggered by neural activation (termed neurovascular coupling or functional hyperemia), a critical mechanism that matches oxygen and nutrient delivery with the increased demands in active brain regions. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-10
Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial
60/100 ✓ Peer-reviewed Clinical trials Frontiers in aging neuroscience
Key finding: Alzheimer's disease (AD) is associated with severe cognitive impairments as well as some metabolic defects. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-10
Network abnormalities and interneuron dysfunction in Alzheimer disease
36/100 ✓ Peer-reviewed Brain scans and imaging Nature reviews. Neuroscience
Key finding: The function of neural circuits and networks can be controlled, in part, by modulating the synchrony of their components' activities. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-10
HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology
42/100 ✓ Peer-reviewed Down syndrome and Alzheimer's Free radical biology & medicine
Key finding: Interestingly, many genes encoded by chromosome 21, in addition to being primarily linked to amyloid-beta peptide (Aβ) pathology, are responsible for increased oxidative stress (OS) conditions that also result as a consequence of reduced antioxidant system efficiency. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-09
Can mindfulness-based interventions influence cognitive functioning in older adults? A review and considerations for future research
53/100 ✓ Peer-reviewed Prevention trials Aging & mental health
Key finding: We conclude that eight-week MBI for older adults are feasible, but results on cognitive improvement are inconclusive due a limited number of studies, small sample sizes, and a high risk of bias. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-08
Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease
39/100 ✓ Peer-reviewed Inflammation and the immune system Journal of neuroscience research
Key finding: Recent research suggests that NLRP3 could possibly be used in targeted therapies to alleviate neuroinflammation. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2016-11-07
Incidence and impact of subclinical epileptiform activity in Alzheimer's disease
52/100 ✓ Peer-reviewed Cognitive tests and assessment Annals of neurology
Key finding: Extended monitoring detects subclinical epileptiform activity in a substantial proportion of patients with AD. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2016-11-07
End of Life Care: A Scoping Review of Experiences of Advance Care Planning for People with Dementia
38/100 ✓ Peer-reviewed End-of-life care Dementia (London, England)
Key finding: We conducted a scoping review of studies exploring decisions associated with the EoLC of people with dementia.
Full summary, score breakdown and related studies → Original source
-
2016-11-05
Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy
58/100 ✓ Peer-reviewed Inflammation and the immune system Brain : a journal of neurology
Key finding: Neuroinflammatory changes are thought to be major contributors to Alzheimer's disease pathophysiology, even if their precise role still remains largely debated. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-04
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
59/100 ✓ Peer-reviewed Brain scans and imaging Nature Communications
Key finding: Comparison between cognitively matched normal adult subgroups, delineated according to the amyloid biomarker, revealed abnormal degeneration in basal forebrain, but not entorhinal cortex.
Full summary, score breakdown and related studies → Original source
-
2016-11-04
Autophagy flux in CA1 neurons of Alzheimer hippocampus: Increased induction overburdens failing lysosomes to propel neuritic dystrophy
51/100 ✓ Peer-reviewed Brain tissue and pathology Autophagy
Key finding: Here, for the first time, we have comprehensively evaluated the entire autophagic process specifically in CA1 pyramidal neurons of hippocampus from early and late-stage AD subjects and nondemented controls. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-03
Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice
36/100 ✓ Peer-reviewed Treatments The Journal of Neuroscience
Key finding: In addition, functional readouts such as calcium overload may be a more useful outcome measure to monitor treatment efficacy in models of Alzheimer's disease compared with amyloid burden alone.
Full summary, score breakdown and related studies → Original source
-
2016-11-03
Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders
38/100 ✓ Peer-reviewed Risk factors Neurological research
Key finding: Overproduction of reactive species, notably reactive oxygen (ROS) and nitrogen (RNS) species along with the failure of balance by the body's antioxidant enzyme systems results in destruction of cellular structures, lipids, proteins, and genetic materials such as DNA and RNA.
Full summary, score breakdown and related studies → Original source
-
2016-11-03
Targeting neuroinflammation in Alzheimer's disease
47/100 ✓ Peer-reviewed Inflammation and the immune system Journal of inflammation research
Key finding: Alzheimer's disease (AD) accounts for approximately 60%-80% of all dementia cases. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2016-11-03
Causes of nursing home placement for older people with dementia: a systematic review and meta-analysis
65/100 ✓ Peer-reviewed Caregiving International psychogeriatrics
Key finding: We recommend focusing on cognitive enhancement strategies, assessment and management of BPSD, and carer education and support to delay nursing home placement. +1 more finding
Full summary, score breakdown and related studies → Original source
Browse the library by subject, with the full score breakdown →